Moreover, the prevalence of MetS is 58% higher in psychiatric patients than in the general population (20), with prominent anorexigenic and orexigenic hormones leptin and ghrelin identified to be associated with psychiatric disorders including schizophrenia, bipolar disorder and major depression (21–23). This evidence concerns the gene GHRL and major depressive disorder.